Antinociception synergy between the peripheral and spinal sites of the heme oxygenase-carbon monoxide pathway

Brazilian Journal of Medical and Biological Research

Volumn 42, Issue 1, 2009, Pages 141-147

  Nascimento, C G O ^a   Branco, L G S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antinoception; Carbon monoxide; Formalin; Hypemociception; Nociception

Indexed keywords

CARBON MONOXIDE; CYCLIC GMP; DEUTEROPORPHYRIN DERIVATIVE; FORMALDEHYDE; GUANYLATE CYCLASE; HEME DERIVATIVE; HEME OXYGENASE; HEME OXYGENASE INHIBITOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANTINOCICEPTION; CONFERENCE PAPER; ENVIRONMENT; ENZYME ACTIVATION; ENZYME SUBSTRATE; EXPERIMENTAL MODEL; FOOT; NOCICEPTION; NONHUMAN; RAT; SIGNAL TRANSDUCTION; SPINAL CORD;

ANIMALIA; RATTUS;

EID: 62749140082     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2009000100020     Document Type: Conference Paper

References (38)

1. Dawson TM, Snyder SH. Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J Neurosci 1994; 14: 5147-5159.
2. Mancuso C. Heme oxygenase and its products in the nervous system. Antioxid Redox Signal 2004; 6: 878-887.
3. Maines MD. The heme oxygenase system: update 2005. Antioxid Redox Signal 2005; 7: 1761-1766.
4. Mancuso C, Perluigi M, Cini C, De Marco C, Giuffrida Stella AM, Calabrese V. Heme oxygenase and cyclooxygenase in the central nervous system: a functional interplay. J Neurosci Res 2006; 84: 1385-1391.
5. Marks GS, Brien JF, Nakatsu K, McLaughlin BE. Does carbon monoxide have a physiological function? Trends Pharmacol Sci 1991; 12: 185-188.
6. Morita T, Perrella MA, Lee ME, Kourembanas S. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci U S A 1995; 92: 1475-1479.
7. Steiner AA, Colombari E, Branco LG. Carbon monoxide as a novel mediator of the febrile response in the central nervous system. Am J Physiol 1999; 277: R499-R507.
8. Steiner AA, Reste G, Branco LG. Role of the brain heme oxygenase-carbon monoxide pathway in stress fever in rats. Neurosci Lett 2003; 341: 193-196.
9. Paro MF, Steiner AA, Branco LGS. Thermoregulatory response to hypoxia after inhibition of the central heme oxygenase-carbon monoxide pathway. J Therm Biol 2001; 26: 343.
10. Steiner AA, Branco LG, Cunha FQ, Ferreira SH. Role of the haeme oxygenase/carbon monoxide pathway in mechanical nociceptor hypersensitivity. Br J Pharmacol 2001; 132: 1673-1682.
11. Nascimento CG, Branco LG. Role of the peripheral heme oxygenase-carbon monoxide pathway on the nociceptive response of rats to the formalin test: evidence for a cGMP signaling pathway. Eur J Pharmacol 2007; 556: 55-61.
12. Nascimento CG, Branco LG. Role of the spinal cord heme oxygenase-carbon monoxide-cGMP pathway in the nociceptive response of rats. Eur J Pharmacol 2008; 581: 71-76.
13. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983; 16: 109-110.
14. Linden IB, Tokola O, Karlsson M, Tenhunen R. Fate of haem after parenteral administration of haem arginate to rabbits. J Pharm Pharmacol 1987; 39: 96-102.
15. Almeida FR, Schivo IR, Lorenzetti BB, Ferreira SH. Chronic intrathecal cannulation enhances nociceptive responses in rats. Braz J Med Biol Res 2000; 33: 949-956.
16. Mestre C, Pelissier T, Fialip J, Wilcox G, Eschalier A. A method to perform direct transcutaneous intrathecal injection in rats. J Pharmacol Toxicol Methods 1994; 32: 197-200.
17. Abraham NG, Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 2008; 60: 79-127.
18. Li X, Clark JD. Spinal cord heme oxygenase participates in glutamate-induced pain-related behaviors. Eur J Pharmacol 2002; 450: 43-48.
19. Steiner AA, Branco LG. Central CO-heme oxygenase pathway raises body temperature by a prostaglandin-independent way. J Appl Physiol 2000; 88: 1607-1613.
20. Anning PB, Chen Y, Lamb NJ, Mumby S, Quinlan GJ, Evans TW, et al. Iron overload upregulates haem oxygenase 1 in the lung more rapidly than in other tissues. FEBS Lett 1999; 447: 111-114.
21. Ponka P. Cell biology of heme. Am J Med Sci 1999; 318: 241-256.
22. Shibahara S. Heme oxygenase-regulation of and physiological implication in heme catabolism. In: Fujita H, Medina OH (Editors), Regulation of heme protein synthesis. Palo Alto: AlphaMed Press; 1994. p 103-116.
23. Takahashi K, Hara E, Suzuki H, Sasano H, Shibahara S. Expression of heme oxygenase isozyme mRNAs in the human brain and induction of heme oxygenase-1 by nitric oxide donors. J Neurochem 1996; 67: 482-489.
24. Ewing JF, Maines MD. In situ hybridization immunohistochemical localization of heme oxygenase-2 mRNA and protein in normal rat brain: differential distribution of isoenzyme 1 and 2. Mol Cell Neurosci 1992; 3: 559-570.
25. Dubuisson D, Dennis SG. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 1977; 4: 161-174.
26. Yashpal K, Coderre TJ. Influence of formalin concentration on the antinociceptive effects of anti-inflammatory drugs in the formalin test in rats: separate mechanisms underlying the nociceptive effects of low- and high-concentration formalin. Eur J Pain 1998; 2: 63-68.
27. Coderre TJ, Fundytus ME, McKenna JE, Dalal S, Melzack R. The formalin test: a validation of the weighted-scores method of behavioural pain rating. Pain 1993; 54: 43-50.
28. Tjolsen A, Berge OG, Hunskaar S, Rosland JH, Hole K. The formalin test: an evaluation of the method. Pain 1992; 51: 5-17.
29. Coderre TJ, Vaccarino AL, Melzack R. Central nervous system plasticity in the tonic pain response to subcutaneous formalin injection. Brain Res 1990; 535: 155-158.
30. Wheeler-Aceto H, Cowan A. Buprenorphine and morphine cause antinociception by different transduction mechanisms. Eur J Pharmacol 1991; 195: 411-413.
31. Johnson RA, Kozma F, Colombari E. Carbon monoxide: from toxin to endogenous modulator of cardiovascular functions. Braz J Med Biol Res 1999; 32: 1-14.
32. Dudhgaonkar SP, Tandan SK, Kumar D, Arunadevi R, Prakash VR. Synergistic interaction between meloxicam and aminoguanidine in formalin-induced nociception in mice. Eur J Pain 2008; 12: 321-328.
33. Ortiz MI, Castaneda-Hernandez G. Examination of the interaction between peripheral lumiracoxib and opioids on the 1% formalin test in rats. Eur J Pain 2008; 12: 233-241.
34. Dogrul A, Gul H, Akar A, Yildiz O, Bilgin F, Guzeldemir E. Topical cannabinoid antinociception: synergy with spinal sites. Pain 2003; 105: 11-16.
35. Cunha FQ, Teixeira MM, Ferreira SH. Pharmacological modulation of secondary mediator systems-cyclic AMP and cyclic GMP- on inflammatory hyperalgesia. Br J Pharmacol 1999; 127: 671-678.
36. Ferreira SH, Duarte ID, Lorenzetti BB. The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release. Eur J Pharmacol 1991; 201: 121-122.
37. Sachs D, Cunha FQ, Ferreira SH. Peripheral analgesic blockade of hypernociception: activation of arginine/NO/cGMP/protein kinase G/ ATP-sensitive K+ channel pathway. Proc Natl Acad Sci U S A 2004; 101: 3680-3685.
38. Soares AC, Duarte ID. Dibutyryl-cyclic GMP induces peripheral antinociception via activation of ATP-sensitive K(+) channels in the rat PGE2-induced hyperalgesic paw. Br J Pharmacol 2001; 134: 127-131.